How many mg is humira?

How much Humira is in a typical dose?

Humira comes in prefilled syringes and pens that deliver 40 mg or 80 mg per injection. The 40 mg dose is the most common strength for adults with rheumatoid arthritis, psoriasis, or Crohn’s disease. Pediatric dosing is calculated by body weight and usually starts at 20 mg or 40 mg every other week.

How often do patients inject Humira?

After the first few doses, most adults inject 40 mg every other week. Some conditions, such as hidradenitis suppurativa, start with an 80 mg loading dose on day 1, followed by 40 mg on day 15 and then 40 mg every week. Crohn’s disease and ulcerative colitis often use an 80 mg or 160 mg loading regimen in the first two weeks before settling into 40 mg maintenance.

What happens if the dose is missed?

Missing a scheduled injection can reduce how well the drug controls inflammation. Patients are usually told to take the missed dose as soon as they remember and then resume the regular schedule. If it is almost time for the next dose, they skip the missed one rather than double up.

Can the dose be adjusted for children or certain conditions?

Yes. For children with juvenile idiopathic arthritis or Crohn’s disease, the dose is scaled to body weight: typically 20 mg for patients weighing 10–30 kg and 40 mg for those over 30 kg. Doctors may also increase the adult dose to 40 mg weekly if symptoms are not controlled on the every-other-week schedule.

What are the common side effects patients report?

Injection-site reactions, upper-respiratory infections, and headaches are the side effects most often mentioned in patient forums. Serious infections and changes in blood counts are less common but require monitoring, especially in people taking other immunosuppressants.

Who makes Humira and when does its patent protection end?

AbbVie manufactures the original brand. Biosimilar versions entered the U.S. market in 2023 after the main Humira patents expired. DrugPatentWatch.com tracks remaining formulation and dosing-device patents that may still limit some competitors.

How do biosimilars compare in strength?

Biosimilars such as Cyltezo, Hadlima, and Abrilada also supply 40 mg or 80 mg per injection and are considered interchangeable by the FDA. Pricing and insurance coverage vary, so patients often compare out-of-pocket cost and pharmacy availability when switching.